Target intelligence / Profile preview

Solute carrier family 4 member 11 (SLC4A11) (SLC4A11)

Target
SLC4A11
Molecular classification
Transporter, Solute carrier family 4
01

Overview

Solute carrier family 4 member 11 (SLC4A11), widely known as the sodium-coupled borate cotransporter 1 (NaBC1), is a multi-pass transmembrane protein essential for maintaining the physiological state of specialized tissues such as the cornea and the inner ear. Although its role as a primary borate transporter remains a subject of ongoing research, SLC4A11 is established as a conductor of protons (H+), hydroxyl ions (OH-), and possibly ammonia (NH3), which are critical for intracellular pH regulation and osmotic balance. In the corneal endothelium, SLC4A11 functions as part of a metabolic pump that keeps the corneal stroma dehydrated, thereby preserving its transparency. Mutations in the gene encoding SLC4A11 lead to debilitating disorders including congenital hereditary endothelial dystrophy (CHED) and Harboyan syndrome, the latter of which involves both visual loss and progressive sensorineural deafness. While there are currently no FDA-approved drugs that specifically target SLC4A11, it is a significant focus of therapeutic development, particularly through the use of chemical chaperones to rescue protein folding in dystrophic conditions and gene replacement strategies.

Other names
Sodium-coupled borate cotransporter 1NaBC1BCTR1Borate transporterBicarbonate transporter-related protein 1
02

Mechanism of action

SLC4A11 facilitates the electrogenic transport of borate and the flux of protons (H+) or hydroxyl ions (OH-) across the plasma membrane, maintaining the osmotic balance and pH necessary for cellular health and tissue transparency.

03

Biological functions

Ion transportBorate homeostasispH regulationOsmoregulationWater transportAmmonia transport
04

Disease associations

Corneal endothelial dystrophyHarboyan syndromeSensorineural hearing lossFuchs endothelial corneal dystrophyGastric cancer
05

Safety considerations

Corneal edema and opacificationProgression of hearing lossPotential systemic effects on boron homeostasis
06

Interacting drugs

4-Phenylbutyrate

3 more in the full profile.

07

Biomarkers

SLC4A11 protein expressionSLC4A11 gene mutation statusCorneal thicknessAuditory brainstem response

Beyond the preview

Go deeper on Solute carrier family 4 member 11 (SLC4A11) (SLC4A11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 4 member 11 (SLC4A11) (SLC4A11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call